BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
53.00
+0.08 (0.15%)
At close: Jun 27, 2025, 2:57 PM CST
SHA:688166 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 812.68 | 765.35 | 998.05 | 1,180 | 336.84 | 339.53 | Upgrade
|
Trading Asset Securities | - | - | 50.62 | 50.12 | 0.76 | 180.04 | Upgrade
|
Cash & Short-Term Investments | 812.68 | 765.35 | 1,049 | 1,230 | 337.6 | 519.58 | Upgrade
|
Cash Growth | -21.52% | -27.02% | -14.78% | 264.48% | -35.02% | -27.33% | Upgrade
|
Accounts Receivable | 285.23 | 339.5 | 308.88 | 307.47 | 373.85 | 177.27 | Upgrade
|
Other Receivables | 2.03 | 6.66 | 19.91 | 18.78 | 3.75 | 0.92 | Upgrade
|
Receivables | 287.26 | 346.17 | 328.79 | 326.25 | 377.59 | 178.19 | Upgrade
|
Inventory | 365.68 | 364.61 | 344.63 | 280.35 | 200.06 | 203.2 | Upgrade
|
Prepaid Expenses | - | - | 3.65 | 5.83 | 4.48 | 5.76 | Upgrade
|
Other Current Assets | 105.97 | 164.14 | 114 | 95.39 | 73.27 | 39.64 | Upgrade
|
Total Current Assets | 1,572 | 1,640 | 1,840 | 1,938 | 993.01 | 946.36 | Upgrade
|
Property, Plant & Equipment | 2,713 | 2,705 | 2,489 | 2,076 | 1,378 | 452.5 | Upgrade
|
Long-Term Investments | 124.11 | 437.06 | 425.86 | 399.33 | 348.28 | 156.88 | Upgrade
|
Goodwill | 3.12 | 3.12 | 7.5 | 7.5 | 7.5 | - | Upgrade
|
Other Intangible Assets | 88.29 | 89.48 | 93.66 | 81.64 | 80.84 | 48.76 | Upgrade
|
Long-Term Accounts Receivable | - | 2.1 | - | - | - | - | Upgrade
|
Long-Term Deferred Tax Assets | 82.36 | 73.55 | 42.28 | 23.94 | 19.86 | 18.16 | Upgrade
|
Long-Term Deferred Charges | 226.22 | 57.49 | 30.18 | 26.87 | 25.83 | 33 | Upgrade
|
Other Long-Term Assets | 476.44 | 156.03 | 104.09 | 107.73 | 115.86 | 172.11 | Upgrade
|
Total Assets | 5,285 | 5,164 | 5,032 | 4,661 | 2,970 | 1,828 | Upgrade
|
Accounts Payable | 209.47 | 266 | 228.18 | 252.19 | 211.89 | 79.63 | Upgrade
|
Accrued Expenses | 43.14 | 75.5 | 72.31 | 69.04 | 61.72 | 37.47 | Upgrade
|
Short-Term Debt | 131.42 | 115.26 | 156.87 | 124.38 | 257.05 | 140.02 | Upgrade
|
Current Portion of Long-Term Debt | 480.94 | 516.96 | 397.93 | 313.87 | 16.58 | 2.56 | Upgrade
|
Current Portion of Leases | - | 13.69 | 16.1 | 1.34 | 9.87 | - | Upgrade
|
Current Income Taxes Payable | 8.58 | 16.68 | 14.04 | 14.97 | 3.69 | 5.44 | Upgrade
|
Current Unearned Revenue | 34.88 | 28.02 | 24 | 29.49 | 20.33 | 24.82 | Upgrade
|
Other Current Liabilities | 29.77 | 20.27 | 12.81 | 6.26 | 1.93 | 1.78 | Upgrade
|
Total Current Liabilities | 938.19 | 1,052 | 922.25 | 811.52 | 583.07 | 291.71 | Upgrade
|
Long-Term Debt | 1,613 | 1,580 | 1,615 | 1,576 | 618.69 | 77.52 | Upgrade
|
Long-Term Leases | 8.44 | 10.21 | 21.01 | 6.01 | 0.22 | - | Upgrade
|
Long-Term Unearned Revenue | 73.11 | 74.71 | 26.25 | 26 | 26 | 26 | Upgrade
|
Other Long-Term Liabilities | 36.23 | 10 | 29.82 | - | - | - | Upgrade
|
Total Liabilities | 2,669 | 2,727 | 2,614 | 2,420 | 1,228 | 395.23 | Upgrade
|
Common Stock | 422.47 | 422.47 | 422.47 | 422.47 | 410 | 410 | Upgrade
|
Additional Paid-In Capital | 1,076 | 982.36 | 1,057 | 1,008 | 738.94 | 701.01 | Upgrade
|
Retained Earnings | 1,059 | 1,046 | 897.66 | 743.35 | 555.05 | 345.54 | Upgrade
|
Treasury Stock | -10.01 | -10.01 | - | - | - | - | Upgrade
|
Comprehensive Income & Other | -46.55 | -46.48 | -8.64 | 17.77 | -25.8 | -24.78 | Upgrade
|
Total Common Equity | 2,502 | 2,395 | 2,369 | 2,192 | 1,678 | 1,432 | Upgrade
|
Minority Interest | 114.4 | 42.73 | 48.97 | 50.04 | 63.45 | 0.78 | Upgrade
|
Shareholders' Equity | 2,616 | 2,437 | 2,418 | 2,242 | 1,742 | 1,433 | Upgrade
|
Total Liabilities & Equity | 5,285 | 5,164 | 5,032 | 4,661 | 2,970 | 1,828 | Upgrade
|
Total Debt | 2,234 | 2,236 | 2,207 | 2,022 | 902.42 | 220.1 | Upgrade
|
Net Cash (Debt) | -1,421 | -1,470 | -1,158 | -791.15 | -564.82 | 299.48 | Upgrade
|
Net Cash Growth | - | - | - | - | - | -58.11% | Upgrade
|
Net Cash Per Share | -3.37 | -3.50 | -2.75 | -1.91 | -1.39 | 0.72 | Upgrade
|
Filing Date Shares Outstanding | 431.99 | 422.11 | 422.1 | 422.47 | 410 | 410 | Upgrade
|
Total Common Shares Outstanding | 431.99 | 422.11 | 422.47 | 422.47 | 410 | 410 | Upgrade
|
Working Capital | 633.4 | 587.89 | 917.49 | 1,127 | 409.94 | 654.65 | Upgrade
|
Book Value Per Share | 5.79 | 5.67 | 5.61 | 5.19 | 4.09 | 3.49 | Upgrade
|
Tangible Book Value | 2,410 | 2,302 | 2,267 | 2,103 | 1,590 | 1,383 | Upgrade
|
Tangible Book Value Per Share | 5.58 | 5.45 | 5.37 | 4.98 | 3.88 | 3.37 | Upgrade
|
Buildings | - | 728.65 | 261.26 | 273.4 | 104.72 | 104.72 | Upgrade
|
Machinery | - | 1,122 | 704.8 | 318.41 | 287.37 | 253.45 | Upgrade
|
Construction In Progress | - | 1,167 | 1,736 | 1,666 | 1,131 | 219.14 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.